Skip to search formSkip to main contentSkip to account menu

FK 480

Known as: FK480 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

FR 120480

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Mutual dependence of VIP/PACAP and CCK receptor signaling for a physiological role in duck exocrine pancreatic secretion.
Unlike in rodents, CCK has not been established as a physiological regulator in avian exocrine pancreatic secretion. In the… 
2002
2002
Bovine pancreatic secretion in the first week of life: potential involvement of intestinal CCK receptors
1999
1999
Small intestinal and pancreatic microstructures are modified by an intraduodenal CCK-A receptor antagonist administration in neonatal calves
1998
1998
Guanidinated Casein Hydrolysate Stimulates Pancreatic Secretagogue Release by Direct Action to the Intestine in Rats
Abstract Previously, we observed that pancreatic exocrine secretion was strongly enhanced after duodenal administration of… 
1998
1998
Effect of FK480, a CCK‐A Receptor Antagonist, on Spontaneously Developed Chronic Pancreatitis in WBN/ob Rats
The effect of FK480, a cholecystokinin-A (CCK-A) selective receptor antagonist, on spontaneously developed chronic pancreatitis… 
1998
1998
Augmentation of the inhibitory effect of FK480, a CCK-A receptor antagonist, on pancreatic exocrine secretion by achlorhydria.
The effect of intraluminal acid and cholecystokinin (CCK) receptor blockade on the pancreatic secretory response was examined in… 
1997
1997
Direct contractile effect of cholecystokinin octapeptide on caecal circular smooth muscle cells of guinea pig via both CCK-A and CCK-B/gastrin receptors.
1996
1996
The Effects of Intrathecally Administered FK480, a Cholecystokinin-A Receptor Antagonist, and YM022, a Cholecystokinin-B Receptor Antagonist, on the Formalin Test in the Rat
Cholecystokinin (CCK) is located in the brain and the spinal cord, and CCK antagonist is reported to enhance the analgesic effect… 
1995
1995
Different inhibitory effects of the newly developed CCK receptor antagonists FK480 and KSG-504 on pancreatic exocrine and endocrine secretion in the isolated perfused rat pancreas
1995
1995
Effect of a Novel Cholecystokinin Receptor Antagonist, FK480, Administered Intraduodenally, on Pancreatic Secretion in Rats
The effect of a new cholecystokinin (CCK)-A receptor antagonist, FK480, developed in Japan, on pancreatic exocrine secretion… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)